HIMS logo

Hims & Hers Health Inc. Class A (HIMS)

$33.78

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on HIMS

Market cap

$7.88B

EPS

-0.63

P/E ratio

--

Price to sales

3.33

Dividend yield

--

Beta

2.398763

Price on HIMS

Previous close

$31.86

Today's open

$31.67

Day's range

$31.60 - $34.46

52 week range

$13.74 - $65.30

Profile about HIMS

CEO

Andrew Dudum

Employees

1637

Headquarters

San Francisco, CA

Exchange

New York Stock Exchange

Shares outstanding

233313413

Issue type

Common Stock

HIMS industries and sectors

Consumer Staples

Consumer Products - Household & Personal

News on HIMS

HIMS & HERS HEALTH, INC. INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Hims & Hers Health, Inc.'s Directors and Officers for Breach of Fiduciary Duties – HIMS

NEW YORK--(BUSINESS WIRE)---- $HIMS #NYSE--Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of Hims & Hers Health, Inc. (NYSE: HIMS) failed to manage Hims & Hers in an acceptable manner, breaching their fiduciary duties to Hims & Hers, and whether Hims & Hers and its shareholders have suffered damages as a result. Attorney Joseph A. Pettigrew is heading the investigation—what shareholders need to know: On July 29, 2026, the Federa.

news source

Business Wire • 3 hours ago

news preview

Kaplan Fox Reminds Hims & Hers Health, Inc. (HIMS) Investors of an Investigation into Potential Securities Law Violations

New York, New York--(Newsfile Corp. - August 24, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are a Hims & Hers investor and have suffered losses, or if you have information that could assist in the Hims & Hers investigation, you may CLICK HERE to contact us.

news source

Newsfile Corp • 2 hours ago

news preview

Bragar Eagel & Squire, P.C. is Investigating Hims & Hers Health, Inc. on Behalf of Hims & Hers Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C.  Litigation Partner  Brandon Walker  Encourages Investors Who Suffered Losses In Hims & Hers (HIMS) To Contact Him Directly To Discuss Their Options

news source

GlobeNewsWire • Aug 21, 2026

news preview

HIMS INVESTIGATION: Kessler Topaz Meltzer & Check, LLP Encourages Hims & Hers Health, Inc. (NYSE: HIMS) Investors to Contact the Firm

RADNOR, Pa., Aug. 21, 2026 (GLOBE NEWSWIRE) -- Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, is investigating potential violations of the federal securities laws by Hims & Hers Health, Inc. (NYSE: HIMS) on behalf of investors who purchased or acquired Hims & Hers Health, Inc. securities and experienced significant financial losses.

news source

GlobeNewsWire • Aug 21, 2026

news preview

HIMS Stock More Than Doubled in 6 Months: What's Driving the Rally?

Hims & Hers' rally is fueled by branded weight-loss growth, international expansion, AI efficiencies and a broader specialty portfolio.

news source

Zacks Investment Research • Aug 21, 2026

news preview

Kaplan Fox & Kilsheimer LLP Alerts Investors of Hims & Hers Health, Inc. (HIMS) to an Investigation of Potential Securities Law Violations

New York, New York--(Newsfile Corp. - August 21, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are a Hims & Hers investor and have suffered losses, or if you have information that could assist in the Hims & Hers investigation, you may CLICK HERE to contact us.

news source

Newsfile Corp • Aug 21, 2026

news preview

Hims & Hers' CEO Just Disposed of 78,859 Shares. Here's What Long-Term Investors Should Know.

The transaction involved 78,859 shares with a total value of $2.2 million as of August 14. This non-discretionary disposition reduced the CEO's direct holdings by 7% while his total equity position remains at about 9.7 million shares.

news source

The Motley Fool • Aug 19, 2026

news preview

The CTO of Hims & Hers Just Gave Up Nearly $2.7 Million in Stock. Here's What It Actually Means

The transaction involved the disposal of 95,798 shares with an estimated value of about $2.7 million based on the transaction date market close. The transaction was non-discretionary, executed to cover tax obligations related to the vesting and settlement of restricted stock units (RSUs).

news source

The Motley Fool • Aug 19, 2026

news preview

An Insider at Hims & Hers Disposed of Over $3 Million in Stock. Here's What Long-Term Investors Should Know

The total transaction value reached $3.2 million based on a weighted average execution price of $31.92 per share. The activity involved the exercise of 101,208 stock options and the withholding of 36,437 shares by the company to satisfy tax obligations.

news source

The Motley Fool • Aug 19, 2026

news preview

Hims & Hers' Policy Chief Just Filed an Insider Transaction. Here's What It Means.

The disposition involved 16,147 shares for a total transaction value of about $455,000 at $28.15 per share. This was a non-discretionary transaction executed to satisfy tax withholding obligations following the vesting of restricted stock units.

news source

The Motley Fool • Aug 19, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Hims & Hers Health Inc. Class A

Open an M1 investment account to buy and sell Hims & Hers Health Inc. Class A commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in HIMS on M1